CRS-207 is a bacterial based vaccine of attenuated Listeria monocytogenes which was modified to express mesothelin (MSLN)—A tumour associated antigen (cell-surface glycoprotein) expressed in PDAC. The gene discussed is MSLN; the disease is neoplasm.